Lucas C. Godoy

Also affiliated with University of Ottawa, University of Toronto, Institute for Clinical Evaluative Sciences

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Anticoagulation in Patients With COVID-19”.

Anticoagulation in Patients With COVID-19

Journal of the American College of Cardiology(2022)10.1016/j.jacc.2021.12.023

N/A

2.0DataRank · unranked

58 citations

Gregg W. Stone, Anuradha Lala, Emilia Bagiella, Pedro Moreno, Girish N. Nadkarni +11 more

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Bristol Research (University of Bristol)(2021)10.17863/cam.76384

N/A

0.957DataRank · unranked

589 citations

ACTIV-4a Investigators, REMAP-CAP Investigators, Matthew D. Neal, Bryan J. McVerry, José Carlos Nicolau +94 more

Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19

JACC Advances(2024)10.1016/j.jacadv.2023.100780

N/A

0.292DataRank · unranked

6 citations

Matthew D. Neal, Ewan C. Goligher, Mary Cushman, Brett L. Houston, Charlotte Bradbury +35 more

Causes of Death After Coronary Revascularization in Patients With Diabetes

The Annals of Thoracic Surgery(2024)10.1016/j.athoracsur.2024.12.013

N/A

0.208DataRank · unranked

3 citations

Valentı́n Fuster, Louai Razzouk, George Dangas, Sanjum S. Sethi, Mandeep S. Sidhu +4 more

Mortality After Multivessel Revascularization in Patients With Diabetes and Acute Coronary Syndromes

JACC Advances(2024)10.1016/j.jacadv.2024.101203

N/A

0DataRank · unranked

3 citations

Michael E. Farkouh, Peter C. Austin, Baiju R. Shah, Feng Qiu, Maneesh Sud +11 more

On-Treatment Change in d -Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19

Arteriosclerosis Thrombosis and Vascular Biology(2024)10.1161/atvbaha.124.321108

N/A

0DataRank · unranked

0 citations

Joshua Froess, Thomas L. Ortel, Ryan Zarychanski, Jeffrey S. Berger, Mary Cushman +11 more